 fewer ulcers observed during 1 year of
follow-up.535 A systemic review also suggested that lowmolecular-weight heparin may decrease VLUs at 3 months
by w87%.536 More evidence is needed to conﬁrm these results, and whether the new oral anticoagulants offer antiﬁbrotic beneﬁts remains unproven.
Long-term therapeutic anticoagulation is associated
with lower DVT recurrence rates and, depending